Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Magn Reson ; 256: 34-42, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25996514

RESUMEN

Nuclear magnetic resonance (NMR) provides a powerful suite of tools for studying oil in reservoir core plugs at the laboratory scale. Low-field magnets are preferred for well-log calibration and to minimize magnetic-susceptibility-induced internal gradients in the porous medium. We demonstrate that careful data processing, combined with prior knowledge of the sample properties, enables real-time acquisition and interpretation of saturation state (relative amount of oil and water in the pores of a rock). Robust discrimination of oil and brine is achieved with diffusion weighting. We use this real-time analysis to monitor the forced displacement of oil from porous materials (sintered glass beads and sandstones) and to generate capillary desaturation curves. The real-time output enables in situ modification of the flood protocol and accurate control of the saturation state prior to the acquisition of standard NMR core analysis data, such as diffusion-relaxation correlations. Although applications to oil recovery and core analysis are demonstrated, the implementation highlights the general practicality of low-field NMR as an inline sensor for real-time industrial process control.

2.
Langmuir ; 20(17): 7313-22, 2004 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-15301521

RESUMEN

Electron paramagnetic resonance, viscosity, and small-angle neutron scattering (SANS) measurements have been used to study the interaction of mixed anionic/nonionic surfactant micelles with the polyampholytic protein gelatin. Sodium dodecyl sulfate (SDS) and the nonionic surfactant dodecylmalono-bis-N-methylglucamide (C12BNMG) were chosen as "interacting" and "noninteracting" surfactants, respectively; SDS micelles bind strongly to gelatin but C12BNMG micelles do not. Further, the two surfactants interact synergistically in the absence of the gelatin. The effects of total surfactant concentration and surfactant mole fraction have been investigated. Previous work (Griffiths et al. Langmuir 2000, 16 (26), 9983-9990) has shown that above a critical solution mole fraction, mixed micelles bind to gelatin. This critical mole fraction corresponds to a micelle surface that has no displaceable water (Griffiths et al. J. Phys. Chem. B 2001, 105 (31), 7465). On binding of the mixed micelle, the bulk solution viscosity increases, with the viscosity-surfactant concentration behavior being strongly dependent on the solution surfactant mole fraction. The viscosity at a stoichiometry of approximately one micelle per gelatin molecule observed in SDS-rich mixtures scales with the surface area of the micelle occupied by the interacting surfactant, SDS. Below the critical solution mole fraction, there is no significant increase in viscosity with increasing surfactant concentration. Further, the SANS behavior of the gelatin/mixed surfactant systems below the critical micelle mole fraction can be described as a simple summation of those arising from the separate gelatin and binary mixed surfactant micelles. By contrast, for systems above the critical micelle mole fraction, the SANS data cannot be described by such a simple approach. No signature from any unperturbed gelatin could be detected in the gelatin/mixed surfactant system. The gelatin scattering is very similar in form to the surfactant scattering, confirming the widely accepted picture that the polymer "wraps" around the micelle surface. The gelatin scattering in the presence of deuterated surfactants is insensitive to the micelle composition provided the composition is above the critical value, suggesting that the viscosity enhancement observed arises from the number and strength of the micelle-polymer contact points rather than the gelatin conformation per se.

3.
Aust Dent J ; 49(4): 171-6, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15762337

RESUMEN

BACKGROUND: The aim of this study was to de the role of the nasal septum in embryonic facial development. METHODS: Nasal septal growth and facial development were examined in sagittally-sectioned 6-9 week human foetuses and compared to previously published data for later prenatal periods. To complement this data a cephalometric study of a child with untreated warfarin embryopathy was undertaken since a previous study in rats had shown warfarin exposure interferes with septal growth. RESULTS: The results showed that prenatal septal growth was maximal during the 6-9 week period and resulted in the establishment of a facial profile that was maintained until birth. This critical of growth corresponds to the period of warfarin exposure of the human foetus that results warfarin embryopathy. The cephalometric examination of a child with untreated warfarin embryopathy showed a combination of short anterior cranial base and a short maxilla had contributed to a significant retrusion of the maxilla suggestive of failure of the midface to devel the 6-9 week period. CONCLUSION: These findings would support the hypothesis that the nasal septum plays an active role in embryonic midfacial development.


Asunto(s)
Desarrollo Fetal , Tabique Nasal/embriología , Anomalías Inducidas por Medicamentos/etiología , Anticoagulantes/efectos adversos , Cefalometría , Niño , Anomalías Craneofaciales/inducido químicamente , Cara/embriología , Desarrollo Fetal/efectos de los fármacos , Humanos , Masculino , Maxilar/anomalías , Maxilar/patología , Tabique Nasal/efectos de los fármacos , Tabique Nasal/patología , Base del Cráneo/anomalías , Base del Cráneo/patología , Warfarina/efectos adversos
4.
Langmuir ; 20(4): 1161-7, 2004 Feb 17.
Artículo en Inglés | MEDLINE | ID: mdl-15803691

RESUMEN

The interaction of a partially fluorinated alkyl sulfate, sodium 1H,1H,2H,2H-perfluorooctyl sulfate (C6F13CH2CH2OSO3Na), with the polyampholyte gelatin has been examined in aqueous solution using surface tension and small-angle neutron scattering (SANS). The 19F chemical shift of each fluorine environment in the surfactant is unaltered by the addition of gelatin, indicating that there is no contact between the gelatin and the fluorocarbon core of the micelle. The chemical shift of the two methylene groups closest to the headgroup is altered when gelatin is present, disclosing the location of the polymer. The critical micelle concentration (cmc) of the surfactant, cmc = 17+/-1 mM, corresponds to an effective alkyl chain (CnH2n+1) length of n = 11. In the presence of gelatin, the cmc is substantially reduced as expected, cmc(1) = 4+/-1 mM, which is also consistent with an effective alkyl chain length of n = 11. In the presence of the fluorosurfactant, the monotonic decay of the SANS from the gelatin-only system is replaced by a substantial peak at an intermediate Q value mirroring the micellar interaction. At low ionic strengths, the gelatin/micelle complex can be described by an ellipsoid. At higher ionic strengths, the electrostatic interaction between the micelles is screened and the peak in the gelatin scattering disappears. The correlation length describing the network structure decreases with increasing SDS concentration as the bound micelles promote a collapse of the network.

5.
Radiat Prot Dosimetry ; 97(2): 101-4, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11843348

RESUMEN

A pre-requisite in the setting and enforcement of regulatory limits for exposure to thorium in the workplace is that thorium and its progeny can be accurately measured. Literature surveys have shown that the majority of thorium measurements were performed using either a radiochemical technique, such as alpha or gamma spectroscopy, or ICP-MS. For many methods. there was a separation step to isolate and pre-concentrate thorium from the sample matrix. Thorium was most commonly measured in geological matrices and industrial materials. A survey of current research activity was performed through distribution of a questionnaire to laboratories and national centres. From the rcsponses, four areas of current activity were identified: (i) development of methods for low level thorium determination, (ii) biological monitoring and metabolism of thorium, (iii) environmental monitoring for thorium, and (iv) health risks from X ray contract media. Two key areas for priority research were identified by the thorium Thematic Network: namely sample preparation methods and for traceable standards and reference materials for thorium analysis.


Asunto(s)
Monitoreo de Radiación/métodos , Contaminantes Radiactivos/análisis , Torio/análisis , Exposición a Riesgos Ambientales , Humanos , Espectrometría de Masas/métodos , Espectrometría de Masas/normas , Análisis de Activación de Neutrones , Exposición Profesional , Monitoreo de Radiación/normas , Estándares de Referencia , Factores de Riesgo , Espectrometría gamma , Encuestas y Cuestionarios , Rayos X/efectos adversos
6.
Radiat Prot Dosimetry ; 97(2): 95-100, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11843367

RESUMEN

Accurate measurements of workplace exposure to 232Th and its progeny are required to estimate internal radiation doses received by persons working with thorium-containing materials. However, a small intercomparison carried out in the mid-nineteen nineties raised doubts about the reliability of results obtained by methods available for measurement of thorium. An EC-funded thematic network was therefore established to bring together experts in the field of thorium analysis in order to coordinate research activity and identify best analytical practice. requirements for reference materials. etc. This network has now successfully completed its work programme. which included a survey to determine future research needs; a series of intercomparisons to test the performance of methods for measuring thorium in workplace materials, and a workshop held to promote best practice and transfer information to regulatory authorities and industry. Results of the work have been used to make various recommendations concerning future needs in this field.


Asunto(s)
Monitoreo de Radiación/métodos , Contaminantes Radiactivos/análisis , Torio/análisis , Humanos , Análisis de Activación de Neutrones , Exposición Profesional , Monitoreo de Radiación/normas , Estándares de Referencia , Espectrometría gamma , Reino Unido
7.
Int J Exp Pathol ; 81(1): 51-6, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10718864

RESUMEN

There is evidence from knock-out mice that the extrahepatic vitamin K-dependent protein, matrix gla protein, is necessary to prevent arterial calcification. The aim of this study was to determine if a warfarin treatment regimen in rats, designed to cause extra-hepatic vitamin K deficiency, would also cause arterial calcification. Sprague-Dawley rats were treated from birth for 5-12 weeks with daily doses of warfarin and concurrent vitamin K1. This treatment causes an extrahepatic vitamin K deficiency without affecting the vitamin K-dependent blood clotting factors. At the end of treatment the rats were killed and the vascular system was examined for evidence of calcification. All treated animals showed extensive arterial calcification. The cerebral arteries and the veins and capillaries did not appear to be affected. It is likely that humans on long-term warfarin treatment have extrahepatic vitamin K deficiency and hence they are potentially at increased risk of developing arterial calcification.


Asunto(s)
Arteriopatías Oclusivas/etiología , Calcinosis/etiología , Deficiencia de Vitamina K/complicaciones , Warfarina/efectos adversos , Animales , Ratas , Ratas Sprague-Dawley , Deficiencia de Vitamina K/inducido químicamente
8.
Epilepsia ; 40(7): 980-4, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10403223

RESUMEN

PURPOSE: To determine whether anticonvulsant exposure during human pregnancy caused an increase of the abnormal form of prothrombin, known as PIVKA-II (prothrombin induced by vitamin K absence for factor II), and a decrease in total prothrombin, in the blood of the newborn. METHODS: Cord blood was collected from the placenta at the time of parturition from 12 women who had received anticonvulsant therapy during pregnancy and from 11 control women. RESULTS: PIVKA-II was present in cord blood from control mothers at low or nondetectable levels. In the same samples, total prothrombin concentrations were approximately 50% of adult levels, but there was wide variation between individuals. Exposure to carbamazepine (CBZ) alone during pregnancy was associated with markedly increased PIVKA-II levels in four of six samples and decreased total prothrombin levels for the whole group. High PIVKA-II levels also were recorded in one cord blood sample from a mother who received phenytoin (PHT) and vigabatrin (VGB). Two cases of PHT alone and one of valproic acid (VPA) alone were not associated with increased PIVKA-II levels. CONCLUSIONS: These results are consistent with the hypothesis that some anticonvulsants (particularly CBZ) interfere with vitamin K metabolism during pregnancy and may result in hematologic signs of vitamin K deficiency in the newborn.


Asunto(s)
Anticonvulsivantes/efectos adversos , Biomarcadores de Tumor/análisis , Biomarcadores , Epilepsia/tratamiento farmacológico , Sangre Fetal/química , Recién Nacido/sangre , Complicaciones del Embarazo/tratamiento farmacológico , Precursores de Proteínas/análisis , Protrombina/análisis , Adulto , Biomarcadores de Tumor/sangre , Femenino , Humanos , Embarazo , Vitamina K/sangre , Deficiencia de Vitamina K/sangre
9.
J Environ Monit ; 1(1): 23-32, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11529075

RESUMEN

Inductively coupled plasma atomic emission spectrometry (ICP-AES) is rapidly overtaking atomic absorption spectrometry (AAS) as the method of choice for the determination of toxic metals in workplace air. However, the few ICP-AES methods that have been published are not well characterised in terms of the effectiveness of the sample dissolution procedures described and their validation status. The International Standards Organization (ISO) is currently engaged in developing ISO 15202, which will describe a generic method for the determination of metals and metalloids in airborne particulate matter by ICP-AES. One part of the proposed standard deals with dissolution procedures. The ISO work has been supported by a project carried out in the authors' laboratory to identify, develop and validate sample dissolution procedures for inclusion in the proposed standard. This paper describes an interlaboratory comparison carried out to assess the performance of selected procedures using samples of airborne particulate matter collected on filters with a multiport sampler. Five dissolution procedures were tested. These included an ultrasonic agitation procedure, two hot-plate procedures (based upon NIOSH 7300 and OSHA ID 125G) and two microwave-assisted procedures (based upon EPA 3052). It was shown that the dissolution procedures selected for use in the trial and used internally at HSL generally gave equivalent performance. As expected, a wider spread of results was obtained by participants in the trial. More specifically, there exists some reservation regarding the ability of the ultrasonic and hot-plate procedures to attack fully on a consistent basis some resistant materials, e.g., chromium containing particulate matter. Above all, the trial demonstrated the usefulness of microwave-assisted dissolution procedures in a modern laboratory.


Asunto(s)
Monitoreo del Ambiente/métodos , Metales Pesados/análisis , Exposición Profesional/normas , Espectrofotometría/métodos , Lugar de Trabajo , Calibración , Humanos , Cooperación Internacional , Reproducibilidad de los Resultados , Solubilidad , Manejo de Especímenes , Espectrofotometría/normas
10.
Am J Med Genet ; 71(4): 391-6, 1997 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-9286443

RESUMEN

We present an infant who was exposed to warfarin throughout pregnancy and has warfarin embryopathy. When the child was examined radiologically at 20 months areas of calcification were visible in the septal and alar cartilages of the small external part of the nose. The location of this ectopic calcification is consistent with that seen in an animal model of the warfarin embryopathy. It supports the hypothesis that warfarin interferes with the prenatal growth of the cartilaginous nasal septum by inhibiting the normal formation of a vitamin K-dependent protein that prevents calcification of cartilage. The child also had severe abnormalities of the cervical vertebrae and secondary damage to the spinal cord. Cervical vertebral anomalies are a relatively common finding in the warfarin embryopathy and in the related Binder syndrome.


Asunto(s)
Calcinosis/inducido químicamente , Tabique Nasal , Efectos Tardíos de la Exposición Prenatal , Enfermedades de la Médula Espinal/inducido químicamente , Warfarina/efectos adversos , Adolescente , Deficiencia de Antitrombina III , Calcinosis/diagnóstico por imagen , Vértebras Cervicales/diagnóstico por imagen , Vértebras Cervicales/efectos de los fármacos , Vértebras Cervicales/patología , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Tabique Nasal/diagnóstico por imagen , Tabique Nasal/efectos de los fármacos , Tabique Nasal/patología , Embarazo , Radiografía , Enfermedades de la Médula Espinal/diagnóstico por imagen , Enfermedades de la Médula Espinal/patología
12.
Am J Med Genet ; 58(3): 238-44, 1995 Sep 11.
Artículo en Inglés | MEDLINE | ID: mdl-8533825

RESUMEN

Ten patients with maxillonasal hypoplasia (Binder "syndrome"), who were prenatally exposed to phenytoin (usually in combination with other anticonvulsants), were identified retrospectively. In addition to their facial anomalies, 6 of the patients were radiographed neonatally and showed punctate calcification, characteristic of chondrodysplasia punctata. Evidence is presented that the facial abnormalities seen in these children are due to anticonvulsant-induced vitamin K deficiency, causing abnormal development of the cartilaginous nasal septum. We propose that early vitamin K supplementation of at-risk pregnancies may prevent the development of maxillonasal hypoplasia, which in some patients is severely disfiguring and causes great emotional distress. Correction of this facial defect requires surgical and dental treatment over a long period of time.


Asunto(s)
Anomalías Inducidas por Medicamentos , Anticonvulsivantes/efectos adversos , Condrodisplasia Punctata/inducido químicamente , Cara/anomalías , Fenitoína/efectos adversos , Efectos Tardíos de la Exposición Prenatal , Vitamina K/administración & dosificación , Adulto , Niño , Condrodisplasia Punctata/prevención & control , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Vitamina K/uso terapéutico , Deficiencia de Vitamina K/inducido químicamente , Deficiencia de Vitamina K/prevención & control
13.
Contact Dermatitis ; 32(5): 257-65, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7634778

RESUMEN

Chelating agents and other substances can be used to bind nickel or reduce its penetration through the skin, and hence to reduce the symptoms in subjects with nickel sensitivity. Topical usage is mostly described but, in some studies, chelating agents have been given systemically. The most effective ligand for nickel so far described is 5-chloro-7-iodoquinolin-8-ol. Although normally regarded as safe, its usage in some situations may be limited by concerns about its toxicity. Other ligands with demonstrable effect include ethylenediaminetetraacetic acid in various forms, diphenylglyoxime and dimethylglyoxime. Cation exchange resins can effectively bind nickel and work both in vitro and in vivo. Propylene glycol, petrolatum and lanolin reduce the absorption of nickel through the skin. Corticosteroids and cyclosporin work in nickel dermatitis by suppressing the immunological reaction rather than through an effect on nickel. Studies of the oral administration of ligands such as tetraethylthiuram disulphide have given conflicting results but the use of these agents is limited by hepatoxicity in any case. Some compounds offer potential for use in the prophylaxis of nickel dermatitis. Further work is required to develop the existing agents and to look at the use of novel combinations, such as that of a cation exchanger with a ligand.


Asunto(s)
Quelantes/uso terapéutico , Dermatitis por Contacto , Níquel , Quelantes/química , Quelantes/farmacología , Dermatitis por Contacto/etiología , Dermatitis por Contacto/prevención & control , Disulfiram/farmacología , Disulfiram/uso terapéutico , Ditiocarba/farmacología , Ditiocarba/uso terapéutico , Ácido Edético/farmacología , Ácido Edético/uso terapéutico , Humanos , Ligandos , Níquel/efectos adversos , Níquel/metabolismo , Pomadas , Resinas de Plantas , Relación Estructura-Actividad
14.
Aust Dent J ; 39(2): 88-92, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8018065

RESUMEN

The normal vitamin K status of the human embryo appears to be close to deficiency. Maternal dietary deficiency or use of a number of therapeutic drugs during pregnancy, may result in frank vitamin K deficiency in the embryo. First trimester deficiency results in maxillonasal hypoplasia in the neonate with subsequent facial and orthodontic implications. A rat model of the vitamin K deficiency embryopathy shows that the facial dysmorphology is preceded by uncontrolled calcification in the normally uncalcified nasal septal cartilage, and decreased longitudinal growth of the cartilage, resulting in maxillonasal hypoplasia. The developing septal cartilage is normally rich in the vitamin K-dependent protein matrix gla protein (MGP). It is proposed that functional MGP is necessary to maintain growing cartilage in a non-calcified state. Developing teeth contain both MGP and a second vitamin K-dependent protein, bone gla protein (BGP). It has been postulated that these proteins have a functional role in tooth mineralization. As yet this function has not been established and abnormalities in tooth formation have not been observed under conditions where BGP and MGP should be formed in a non-functional form.


Asunto(s)
Proteínas de la Matriz Extracelular , Huesos Faciales/embriología , Embarazo/fisiología , Cráneo/embriología , Vitamina K/fisiología , Ácido 1-Carboxiglutámico/fisiología , Animales , Proteínas de Unión al Calcio/fisiología , Femenino , Humanos , Osteocalcina/fisiología , Ratas , Deficiencia de Vitamina K/fisiopatología , Proteína Gla de la Matriz
15.
Aust Dent J ; 37(6): 453-60, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1476496

RESUMEN

There is evidence that vitamin K-deficiency during human pregnancy can be caused by the therapeutic use of warfarin or phenytoin. The pregnancy histories of three cases of Binder's syndrome are reported. One was associated with warfarin exposure, one with phenytoin exposure and one with alcohol abuse. It is proposed that Binder's syndrome can be caused by prenatal exposure to agents that cause vitamin K-deficiency. Sprague-Dawley rats were treated from postnatal day 1 to 12 weeks with daily doses of warfarin (100 mg/kg) and concurrent vitamin K1 (10 mg/kg). This regimen creates a net extra-hepatic vitamin K-deficiency. The treated rats developed with a distinct facial appearance characterized by a markedly reduced snout. Histological examination showed that the normally non-calcified septal cartilage was extensively calcified. It is proposed that normal growth of the septal cartilage is necessary for the development of the profile of the nose and midface and that normal growth will only take place while the septal cartilage is uncalcified.


Asunto(s)
Maxilar/anomalías , Hueso Nasal/anomalías , Efectos Tardíos de la Exposición Prenatal , Deficiencia de Vitamina K/complicaciones , Adolescente , Alcoholismo/complicaciones , Aneurisma Roto/tratamiento farmacológico , Animales , Cartílago/efectos de los fármacos , Cartílago/patología , Preescolar , Femenino , Humanos , Lactante , Aneurisma Intracraneal/tratamiento farmacológico , Masculino , Maxilar/efectos de los fármacos , Maxilar/patología , Hueso Nasal/efectos de los fármacos , Hueso Nasal/patología , Tabique Nasal/efectos de los fármacos , Tabique Nasal/patología , Fenitoína/efectos adversos , Embarazo , Complicaciones Cardiovasculares del Embarazo/tratamiento farmacológico , Ratas , Ratas Sprague-Dawley , Tromboflebitis/tratamiento farmacológico , Vitamina K/uso terapéutico , Warfarina/efectos adversos
16.
Teratology ; 46(4): 379-90, 1992 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1412066

RESUMEN

Sprague-Dawley rats were given daily subcutaneous doses of sodium warfarin (100 mg/kg) and vitamin K1 (10 mg/kg) for up to 12 weeks, starting on the day after birth. This dosing regimen creates an extrahepatic vitamin K deficiency while preserving the vitamin K-dependent processes of the liver. Control rats received either vitamin K1 only or were untreated. All rats survived without any signs of hemorrhage. The warfarin-treated rats developed a marked maxillonasal hypoplasia associated with a 11-13% reduction in the length of the nasal bones compared with controls. The length of the posterior part of the skull was not significantly different from controls. In the warfarin-treated rats, the septal cartilage of the nasal septum showed large areas of calcification, not present in controls, and abnormal calcium bridges in the epiphyseal cartilages of the vertebrae and long bones. The ectopic calcification in the septal cartilage may have been the cause of the reduced longitudinal growth of the nasal septum and the associated maxillonasal hypoplasia. It is proposed that (1) the facial features of the human warfarin embryopathy are caused by reduced growth of the embryonic nasal septum, and (2) the septal growth retardation occurs because the warfarin-induced extrahepatic vitamin K deficiency prevents the normal formation of the vitamin K-dependent matrix gla protein in the embryo.


Asunto(s)
Calcinosis/inducido químicamente , Enfermedades de los Cartílagos/inducido químicamente , Maxilar/patología , Hueso Nasal/anomalías , Tabique Nasal/patología , Deficiencia de Vitamina K/inducido químicamente , Warfarina/toxicidad , Animales , Animales Recién Nacidos , Femenino , Placa de Crecimiento/patología , Masculino , Modelos Biológicos , Ratas , Ratas Sprague-Dawley/crecimiento & desarrollo , Cráneo/embriología , Especificidad de la Especie , Vitamina K 1/administración & dosificación , Warfarina/administración & dosificación
17.
Am J Pathol ; 140(1): 45-55, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1731530

RESUMEN

The effects of transforming growth factor-beta (TGF-beta) on the growth of and collagen production by NRK52E cells, a clonal line established from normal rat kidney epithelial cells, have been characterized. NRK52E cells were grown in the absence or presence of TGF-beta for 4 days followed by incubation for 24 hours in serum-free medium containing [3H]proline. The secreted and cell-associated collagens produced by control and experimental cultures were isolated by limited pepsin digestion and differential salt fractionation. TGF-beta inhibited proliferation by about 50% but did not affect overall culture morphology. Both protein and collagen synthesis were increased in experimental cultures, but the increase in total collagen production exceeded that of total protein synthesis. Although NRK52E cells grown in the presence of TGF-beta continued to produce the same types of collagen (types I, III, IV, and V), their relative amounts were changed. In the experimental cultures, type I collagen production was increased eightfold, types III and V collagen levels were increased two-fold, but type IV production was only slightly enhanced. In addition to increasing total collagen production by about fivefold, TGF-beta increased the ratio of type I to type III about threefold but minimally affected the ratio of secreted to cell-associated molecules. These findings establish that TGF-beta specifically affects collagen production in NRK52E cells and that these alterations differ in many ways from the affects of epidermal growth factor. Because TGF-beta increased total collagen expression, these results provide additional evidence implicating this growth factor as a positive mediator of matrix accumulation in renal disease.


Asunto(s)
Colágeno/biosíntesis , Riñón/citología , Riñón/metabolismo , Factor de Crecimiento Transformador beta/farmacología , Animales , División Celular/efectos de los fármacos , Células Cultivadas , Células Epiteliales , Epitelio/metabolismo , Prolina/metabolismo , Biosíntesis de Proteínas , Ratas , Tritio
18.
Lab Invest ; 65(4): 441-50, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1921334

RESUMEN

Effects of chronic exposure to retinoic acid on a cell line (FRLE cells) established from the fetal rat lung type II alveolar epithelial cell have been studied. Chronic exposure to retinoic acid inhibited proliferation and altered the pattern of culture morphology at the light microscopic level. At the ultrastructural level, the development of lamellar body-like structures was inhibited. Although the rates of both total collagen and protein produced per cell were enhanced by chronic retinoic acid exposure, the increase in collagen production exceeded that of total protein synthesis. Chromatographic evaluation of collagen types I, III, IV, and V revealed increases in the amounts of radioactivity incorporated into each collagen type. However, the magnitudes of the increases differed for each collagen type, with the production of type IV collagen being the most enhanced. These analyses also indicated several additional effects on collagen production: 1) collagen type specific alterations in the ratio of secreted to cell associated molecules, 2) an increased ratio of type I homotrimers to type I heterotrimers, and 3) a decreased ratio of type V homotrimers to type V heterotrimers. These results indicate that chronic exposure to retinoic acid selectively affects collagen production in and differentiation of FRLE cells and establish that these changes are opposite to those observed under conditions of chronic exposure to EGF.


Asunto(s)
Colágeno/biosíntesis , Matriz Extracelular/metabolismo , Pulmón/citología , Tretinoina/farmacología , Animales , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Células Cultivadas , Células Epiteliales , Epitelio/efectos de los fármacos , Epitelio/metabolismo , Feto , Pulmón/efectos de los fármacos , Pulmón/metabolismo , Biosíntesis de Proteínas , Ratas
19.
Am J Respir Cell Mol Biol ; 4(5): 455-62, 1991 May.
Artículo en Inglés | MEDLINE | ID: mdl-2021482

RESUMEN

Studies were performed to characterize the effects of acute and chronic exposure to transforming growth factor-beta (TGF-beta) on collagen biosynthesis by fetal rat lung epithelial (FRLE) cells, a cell line established from the fetal rat lung alveolar epithelial cell. Neither condition of exposure to TGF-beta stimulated cell growth, but both conditions increased total protein synthesis. Quantitative evaluation by carboxymethyl-Trisacryl chromatography revealed that FRLE cells synthesized types I, III, IV, and V collagen under all circumstances. Acute and chronic exposure to TGF-beta increased total collagen production approximately 50% and 300%, respectively, with the increases in total collagen production exceeding those of total protein synthesis. In addition, these analyses indicated that the production of types I and III molecules was stimulated to a greater extent than was the synthesis of types IV and V molecules. Both experimental conditions increased the ratio of secreted to cell-associated molecules for types I and III molecules, decreased this ratio for type IV collagen, but minimally affected the culture distribution of type V collagen. Additionally, both conditions of exposure to TGF-beta were found to increase the proportion of the homotrimeric forms of types I and V molecules relative to their heterotrimeric counterparts. Thus, these studies establish that TGF-beta selectively and type-specifically alters collagen production without affecting growth in an epithelial cell line of fetal rat lung origin.


Asunto(s)
Colágeno/biosíntesis , Pulmón/metabolismo , Factor de Crecimiento Transformador beta/farmacología , Animales , División Celular , Línea Celular , Cromatografía , Colágeno/genética , ADN/biosíntesis , Epitelio/efectos de los fármacos , Pulmón/efectos de los fármacos , Pulmón/embriología , Ratas
20.
Lab Invest ; 64(4): 463-73, 1991 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-2016852

RESUMEN

Studies have been performed to evaluate the effects of chronic exposure to epidermal growth factor (EGF) on a cell line (FRLE cells) established from the fetal rat lung type II alveolar epithelial cell. Chronic exposure to EGF enhanced proliferation and altered the culture morphology at the light microscopic level. At the ultrastructural level, chronic exposure to EGF inhibited the expression of lamellar body-like structures that occurs in the absence of EGF. Estimations of total protein and collagen production indicated that chronic exposure to EGF suppressed collagen production without significantly altering total protein synthesis. Quantitative evaluation of the genetic types of collagen (types I, III, IV, and V) produced by FRLE cells revealed decreased production of each collagen type in cultures chronically exposed to EGF. However, the magnitude of the decrease differed for each collagen type, with type III collagen synthesis being suppressed to the greatest extent. Additionally, chronic exposure to EGF resulted in enhanced secretion of types I, III, and IV collagen molecules and an increase in the ratios of type I-homotrimers to type I-heterotrimers and of type V-homotrimers to type V-heterotrimers. These findings demonstrate that chronic exposure to EGF selectively alters collagen expression in a cell line established from the fetal type II pneumocyte.


Asunto(s)
Colágeno/biosíntesis , Factor de Crecimiento Epidérmico/farmacología , Matriz Extracelular/ultraestructura , Pulmón/citología , Animales , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Células Cultivadas , Colágeno/aislamiento & purificación , Células Epiteliales , Epitelio/efectos de los fármacos , Epitelio/fisiología , Matriz Extracelular/efectos de los fármacos , Feto , Cinética , Pulmón/efectos de los fármacos , Pulmón/fisiología , Sustancias Macromoleculares , Prolina/metabolismo , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA